Randomized, Double-Blind, Placebo-Controlled Trial of Shuanghua Baihe Tablets to Prevent Oral Mucositis in Patients With Nasopharyngeal Cancer Undergoing Chemoradiation Therapy-Reference-Cited by-同舟云学术

Randomized, Double-Blind, Placebo-Controlled Trial of Shuanghua Baihe Tablets to Prevent Oral Mucositis in Patients With Nasopharyngeal Cancer Undergoing Chemoradiation Therapy

Published:2018-02 Issue:2 Volume:100 Page:418-426
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Zheng Baomin,Zhu Xiaodong,Liu Mengzhong,Yang Zhenzhou,Yang Ling,Lang Jinyi,Shi Mei,Wu Gang,He Xia,Chen Xiaozhong,Xi Xuping,Zhao Dan,Zhu Guangying

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference43 articles.

1. Nasopharyngeal carcinoma;Chua;Lancet,2016

2. Mucositis in head and neck cancer patients undergoing radiochemotherapy;Santos;Rev Esc Enferm USP,2011

3. Prospective evaluation of incidence and severity of oral mucositis induced by conventional chemotherapy in solid tumors and malignant lymphomas;Nishimura;Support Care Cancer,2012

4. Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer;Yen;Int J Radiat Oncol Biol,2012

5. Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: Demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life;Elting;Cancer,2008

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical efficacy and applicability of natural products in the treatment and prevention of radiotherapy-induced oral mucositis: A systematic review;PLOS ONE;2024-05-23

2. Efficacy of Lvpao Powder on Radiotherapy-Induced Mucositis: A Retrospective Study of 114 Patients with Head and Neck Carcinoma.;Advances in Radiation Oncology;2023-12

3. Multi-trajectories of health-related quality of life and their associated factors in patients with nasopharyngeal carcinoma: A longitudinal study;Radiotherapy and Oncology;2023-09

4. Fosaprepitant Weekly vs Every 3 Weeks for the Prevention of Concurrent Chemoradiotherapy–Induced Nausea and Vomiting;JAMA Network Open;2023-07-27

5. CACA guidelines for holistic integrative management of nasopharyngeal carcinoma;Holistic Integrative Oncology;2023-07-24